Rentokil Initial plc Files Final Results 6-K

TL;DR

Rentokil Initial plc dropped its 6-K with final results, check the numbers.

AI Summary

Rentokil Initial plc filed a Form 6-K on March 7, 2024, reporting its final results. The filing provides information about the company's principal executive office located at Compass House, Manor Royal, Crawley, West Sussex, RH10 9PY, United Kingdom.

Why It Matters

This filing provides an update on Rentokil Initial plc's financial performance and operational status to investors and the market.

Risk Assessment

Risk Level: low — This is a routine filing of final results by a publicly traded company.

Key Players & Entities

• Rentokil Initial plc (company) — Registrant
• 001-41524 (company) — Commission File Number
• Compass House, Manor Royal, Crawley, West Sussex RH10 9PY, United Kingdom (company) — Principal executive office address

FAQ

Key Financial Figures

• $50m — minix gross synergy target increased by $50m   Financial Results 1 AER
• $25m — plan to be accompanied by additional c.$25m of investment in sales and marketing
• $69m — mpletion revised to 2026   - $69m pre-tax net cost synergies achieved in
• $60m — s achieved in FY 23, ahead of guidance ($60m). Expected to deliver a further c.$40m
• $40m — ($60m). Expected to deliver a further c.$40m of net cost synergies in FY 24  
• $325m — oss and net synergy targets raised to c.$325m and c.$225m respectively (previously $2
• $225m — synergy targets raised to c.$325m and c.$225m respectively (previously $275m and $200
• $275m — 5m and c.$225m respectively (previously $275m and $200m). Integration completion revi
• $200m — 225m respectively (previously $275m and $200m). Integration completion revised to 202
• $65m — with net synergies of c.$40m in 2024, c.$65m in 2025 and c.$38m in 2026.  
• $38m — of c.$40m in 2024, c.$65m in 2025 and c.$38m in 2026.   We expect modest No
• $250,000 — rs for the lifetime of the agreement of $250,000 for new customers with qualifying homes

Filing Documents

• a9048f.htm (6-K) — 1494KB
• 0001654954-24-002747.txt ( ) — 1495KB

Forward-looking statements speak only as of the date they are made

Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure Guidance and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.   Summary of financial performance (at CER)   Regional Performance   Revenue   Adjusted Operating Profit   2023£m 2022£m Change% 2023£m 2022£m Change% North America 3,314 1,849 79.2%   618 315 95.9% Pest Control 3,208 1,746 83.7%   599 297 101.8% Hygiene & Wellbeing 106 103 2.5%   19 18 0.7%                 Europe (incl. LATAM) 1078 941 14.6%   210 187 12.5% Pest Control 520 427 21.8%   120 103 16.6% Hygiene & Wellbeing 341 322 5.8%   52 53 (1.8%) France Workwear 217 192 13.2%   38 31 23.6%                 UK & Sub Saharan Africa 394 365 7.9%   95 95 (0.5%) Pest Control 197 182 8.0%   51 47 8.0% Hygiene & Wellbeing 197 183 7.7%   44 48 (8.9%)                 Asia & MENAT 357 321 11.2% &#x

View Full Filing

View this 6-K filing on SEC EDGAR